"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
There have been reports of inadvertent overdosage with Istalol® resulting in systemic effects similar to those seen with systemic beta-adrenergic blocking agents such as dizziness, headache, shortness of breath, bradycardia, bronchospasm, and cardiac arrest. An in vitro hemodialysis study, using 14C timolol added to human plasma or whole blood, showed that timolol was readily dialyzed from these fluids; however, a study of patients with renal failure showed that timolol did not dialyze readily.
Sinus Bradycardia, AV Block, Cardiac Failure, Cardiogenic Shock
Istalol® is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this product in the past.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 7/1/2013
Additional Istalol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.